UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Antipsychotic augmentation vs. monotherapy in schizophrenia: systematic review, meta-analysis and meta-regression analysis Journal article
WORLD PSYCHIATRY, 2017,Volume: 16,Issue: 1,Page: 77-89
Authors:  Galling, Britta;  Roldan, Alexandra;  Hagi, Katsuhiko;  Rietschel, Liz;  Walyzada, Frozan;  Zheng, Wei;  Cao, Xiao-Lan;  Xiang, Yu-Tao;  Zink, Mathias;  Kane, John M.;  Nielsen, Jimmi;  Leucht, Stefan;  Correll, Christoph U.
Favorite | View/Download:20/0 | TC[WOS]:46 TC[Scopus]:0 | Submit date:2018/10/30
Antipsychotics  Polypharmacy  Augmentation  Monotherapy  Schizophrenia  Clozapine  Aripiprazole  
Safety and tolerability of antipsychotic co-treatment in patients with schizophrenia: results from a systematic review and meta-analysis of randomized controlled trials Journal article
EXPERT OPINION ON DRUG SAFETY, 2016,Volume: 15,Issue: 5,Page: 591-612
Authors:  Galling, B;  Roldan, A;  Rietschel, L;  Hagi, K;  Walyzada, F;  Zheng, W;  Cao, XL;  Xiang, YT;  Kane, JM;  Correll, CU
Favorite | View/Download:6/0 | TC[WOS]:16 TC[Scopus]:0 | Submit date:2019/01/07
Monotherapy  Metaanalysis  Antipsychotics  Augmentation  Combination  Polypharmacy  Cotreatment  Adverse Effects  Tolerability  Safety  Schizophrenia